Antibody therapy is a treatment option for several diseases, including multiple myeloma. The logic behind it is relatively simple: A target molecule is selected because of its expression on tumor cells, and the antibody delivers cytotoxic effects. Therapeutic results in multiple myeloma indicate that the anti-CD38 antibodies may have relevant immunotherapeutic properties.
Mechanism of Action of a New Anti-CD38 Antibody: Enhancing Myeloma Immunotherapy
Malavasi, Fabio;Faini, Angelo Corso
2019-01-01
Abstract
Antibody therapy is a treatment option for several diseases, including multiple myeloma. The logic behind it is relatively simple: A target molecule is selected because of its expression on tumor cells, and the antibody delivers cytotoxic effects. Therapeutic results in multiple myeloma indicate that the anti-CD38 antibodies may have relevant immunotherapeutic properties.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
2946.pdf
Accesso riservato
Tipo di file:
PDF EDITORIALE
Dimensione
217.64 kB
Formato
Adobe PDF
|
217.64 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
